EUVIMEDEUVIMED entdecken
Crossref

Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway.

Yifei Le, Jianan Guo, Zhijun Liu, Jing Liu, Ying Liu, Hang Chen, Jiannan Qiu, Cui Wang, Xiaobing Dou, Dezhao Lu

Journal of Ethnopharmacology · 2024

DOI: 10.1016/j.jep.2023.117239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Yifei Le und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: lyf19970605@foxmail.com. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Saponins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition that can have multiple underlying causes. There are no satisfactory chemical or biological drugs for the treatment of NAFLD. Longyasongmu, the bark and root of Aralia elata (Miq.) Seem, is used extensively in traditional Chinese medicine (TCM) and has been used in treating diverse liver diseases including NAFLD. Based on Aralia elata (Miq.) Seem as the main ingredient, Longya Gantai Capsules have been approved for use in China for the treatment of acute hepatitis and chronic hepatitis. Calenduloside E (CE), a natural pentacyclic triterpenoid saponin, is a significant component of saponin isolated from the bark and root of Aralia elata (Miq.) Seem. However, the role and mechanism of anti-NAFLD effects of CE is still unclear. AIM OF THE STUDY: The objective of this study was to examine the potential mechanisms underlying the protective effect of CE on NAFLD. MATERIALS AND METHODS: In this study, an NAFLD model was established by Western diet in apoE-/- mice, followed by treatment with various doses of CE (5 mg/kg, 10 mg/kg). The anti-NAFLD effect of CE was assessed by the liver injury, lipid accumulation, inflammation, and pro-fibrotic phenotype. The mechanism of CE in ameliorating NAFLD was studied through transcriptome sequencing (RNA-seq). In vitro, the mouse hepatocytes (AML-12) were stimulated in lipid mixtures with CE and performed the exploration and validation of the relevant pathways using Western blot, immunofluorescence, etc. RESULTS: The findings revealed a significant improvement in liver injury, lipid accumulation, inflammation, and pro-fibrotic phenotype upon CE administration. Furthermore, RNAseq analysis indicated that the primary pathway through which CE alleviates NAFLD involves pyroptosis-related inflammatory cascade pathways. Furthermore, it was observed that CE effectively suppressed inflammasome-mediated pyroptosis both in vivo and in vitro. Remarkably, the functional enrichment analysis of RNA-seq data revealed that the PI3K-Akt signaling pathway is the primarily Signaling transduction pathway modulated by CE treatment. Subsequent experimental outcomes provided further validation of CE's ability to hinder inflammasome-mediated pyroptosis through the inhibition of PI3K/AKT/NF-κB signaling pathway. CONCLUSIONS: These findings present a novel pharmacological role of CE in exerting anti-NAFLD effects by inhibiting pyroptosis signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseSaponinsMiceAnimalsPyroptosisProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesInflammasomesLiverInflammationLipidsDiet, High-FatOleanolic Acid

Stichwörter der Autor:innen

Calenduloside EInflammationNAFLDPyroptosis

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesInflammasomesSaponinsLipidscalenduloside EOleanolic Acid

Autor:innen und Institutionen

  • School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: lyf19970605@foxmail.com.
  • School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: guojianan23@163.com.
  • School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: enkidu0705@163.com.
  • School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: liujingsx00@163.com.
  • School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: ly1520973684@163.com.
  • School of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China. Electronic address: ChenHang2120@126.com.

Zitieren

APA

Le, Y., Guo, J., Liu, Z., Liu, J., Liu, Y., Chen, H., Qiu, J., Wang, C., Dou, X., & Lu, D. (2024). Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2023.117239

Vancouver

Le Y, Guo J, Liu Z, Liu J, Liu Y, Chen H, et al. Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2023.117239

BibTeX
@article{Le2024,
  author = {Le, Yifei and Guo, Jianan and Liu, Zhijun and Liu, Jing and Liu, Ying and Chen, Hang and Qiu, Jiannan and Wang, Cui and Dou, Xiaobing and Lu, Dezhao},
  title = {Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway},
  journal = {Journal of Ethnopharmacology},
  year = {2024},
  doi = {10.1016/j.jep.2023.117239}
}
Kostenlos starten →